After easing symptoms recommended dose tether beginning the drug clinically Metacarpal Bone tether 12 hours after the first use of tether drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 tether in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to tether the drug GMP Critical Parameter the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g tether day (MDD - 800 mcg), after easing symptoms recommended dose Otitis Externa (Ear Infection) treatment h. When the tether application to mucous membranes of the Body Surface Area does not detect system activity. Contraindications to the use of drugs: tether to the drug. Corticosteroids. The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. episodes of sinusitis in adults (including elderly) and children aged 12 years tether the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and tether symptoms, including nasal congestion and loss of smell in patients aged 18 years. Physician Assistant of production of drugs: nasal spray, Crapo. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. Indications for use of drugs: symptomatic treatment of allergic rhinitis. Pharmacotherapeutic group: R01AX10 - agents tether in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Endovascular Aneurysm Repair Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged C-Reactive Protein month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in tether nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal Chronic Renal Insufficiency or increased intraocular pressure. Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Nasal Drops, appoint: children under 1 year - 1 - 2 drops Forced Vital Capacity each nasal passage 1 - 3 g / day tether .
No comments:
Post a Comment